337 related articles for article (PubMed ID: 25924846)
1. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.
Reis-Alves SC; Traina F; Metze K; Lorand-Metze I
Diagn Pathol; 2015 Apr; 10():44. PubMed ID: 25924846
[TBL] [Abstract][Full Text] [Related]
2. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
3. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
4. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
5. The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes.
Reis-Alves SC; Traina F; Saad ST; Metze K; Lorand-Metze I
Neoplasma; 2010; 57(6):530-6. PubMed ID: 20845991
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
[TBL] [Abstract][Full Text] [Related]
7. Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.
Sandes AF; Kerbauy DM; Matarraz S; Chauffaille Mde L; López A; Orfao A; Yamamoto M
Cytometry B Clin Cytom; 2013 May; 84(3):157-66. PubMed ID: 23475532
[TBL] [Abstract][Full Text] [Related]
8. Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities.
Arroyo JL; Fernández ME; Hernández JM; Orfao A; San Miguel JF; del Cañizo MC
Hematol J; 2004; 5(3):227-33. PubMed ID: 15167909
[TBL] [Abstract][Full Text] [Related]
9. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
Moon HW; Huh JW; Lee M; Hong KS; Chung WS
Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
[TBL] [Abstract][Full Text] [Related]
11. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
Harrington A; Olteanu H; Kroft S
Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
[TBL] [Abstract][Full Text] [Related]
13. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores J; Bárcena P; Rasillo A; Sayagues JM; Sánchez ML; Hernandez-Campo P; Hernandez Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Orfao A
Leukemia; 2008 Jun; 22(6):1175-83. PubMed ID: 18337765
[TBL] [Abstract][Full Text] [Related]
14. Normal variation of bone marrow B-cell precursors according to age - reference ranges for studies in myelodysplastic syndromes in Brazil.
Lorand-Metze I; Longhini AL; Oliveira-Duarte G; Correia RP; Santos-Silva MC; Yamamoto M; Sandes AF; Oliveira AF; Souto EX; Ikoma MRV; Pereira-Cunha FG; Beltrame M; Metze K;
Cytometry B Clin Cytom; 2018 Sep; 94(5):644-650. PubMed ID: 29205788
[TBL] [Abstract][Full Text] [Related]
15. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
[TBL] [Abstract][Full Text] [Related]
16. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
17. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
[TBL] [Abstract][Full Text] [Related]
19. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
